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Herbal compatibility is the knowledge of which herbs to combine in traditional Chinese
medicine (TCM) formulations. The lack of understanding of herbal compatibility is one
of the key problems for the application and popularization of TCM in western society.
Because of the chemical complexity of herbal medicines, it is simpler to begin to
conduct compatibility research based on herbs rather than component plant secondary
metabolites. We have used transcriptome analysis to explore the effects and interactions
of two plant extracts (Kushen and Baituling) combined in Compound Kushen Injection
(CKI). Based on shared chemical compounds and in vitro cytotoxicity comparisons, we
found that both the major compounds in CKI, and the cytotoxicity effects of CKI were
mainly derived from the extract of Kushen (Sophorae flavescentis). We generated and
analyzed transcriptome data from MDA-MB-231 cells treated with single-herb extracts
or CKI and results showed that Kushen contributed to the perturbation of the majority of
cytotoxicity/cancer related pathways in CKI such as cell cycle and DNA replication. We
also found that Baituling (Heterosmilax yunnanensis Gagnep) could not only enhance
the cytotoxic effects of Kushen in CKI, but also activate immune-related pathways.
Our analyses predicted that IL-1β gene expression was upregulated by Baituling in CKI
and we confirmed that IL-1β protein expression was increased using an ELISA assay.
Altogether, these findings help to explain the rationale for combining Kushen and Baituling
in CKI, and show that transcriptome analysis using single herb extracts is an effective
method for understanding herbal compatibility in TCM.
Keywords: transcriptome, herb combination, traditional Chinese medicine, cancer treatment, Compound Kushen
Injection
INTRODUCTION
At present many complex and chronic diseases rely on therapies that combine modern
pharmaceuticals. A similar multiple-herb strategy known as “Fufang” is an essential component
in traditional Chinese medicine (TCM) theory and is used to achieve better therapeutic results, and
reduce side effects and herbal toxicity (1, 2). As a result of thousands of years’ of accumulated
clinical practice, TCM has more than 100,000 formulae and abundant experience that has
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contributed to an understanding of which herbs should
be combined in particular circumstances, herein referred
to as herbal compatibility (3, 4). However, because herbal
medicines are made up of complex mixtures of plant secondary
metabolites, the mechanism of most TCM formulas has not been
explored. This limitation of TCM has become one of the key
problems for its modernization, and hinders the application and
popularization of herbal medicines (5).
Recent rapid developments in analytical chemistry and
molecular biology have provided methods for researchers to
tackle the complex mechanisms of herbal compatibility on a
number of different levels. Usually, these methods focus on one
or a few components within a complex mixture, in attempts
to reveal how preparation/extraction for combined use can
change their concentrations in products or pharmacokinetic
processes in vivo (6–9). However, as a complex mixture
may contain thousands of compounds, it is unclear how
changing one or several components in a TCM formula can
explain and account for the principles and observations of
herbal compatibility. Furthermore, pharmacological models that
measure phenotypes associated with efficacy or proxies for
efficacy are limited in their ability to explain potential therapeutic
effects and mechanisms. New high-throughput technologies
for measuring molecular phenotypes such as gene expression,
and bioinformatic methods can provide systematic ways for
refining and clarifying complex biological processes that result
from hundreds or thousands of molecular interactions. By
applying these methods to the study of TCM, it is possible to
transform the research paradigm from “main active compound
that influences one target” to “multiple components that
influence many network targets” (10, 11). Although it is now
common to apply RNA-sequencing and systematic methods to
study the effects of whole TCM formulae, no literature has
applied these methods to study herbal compatibility. In this
report, we apply transcriptome analysis to identify how the
combination of Kushen (Sophorae flavescentis) and Baituling
(Heterosmilax yunnanensis Gagnep) extracts can account for the
broader and increased effects observed in Compound Kushen
Injection (CKI).
Our model system for dissecting herbal compatibility, CKI,
is derived from an ancient Chinese formula and was approved
by the State Food and Drug Administration (SFDA) of China
in 1995. It is widely used as an adjuvant medicine in the
treatment of carcinomas for pain relief, activation of innate
immune response and reduced side effects in cancer therapy
(12, 13). Our previous results have shown that CKI suppresses the
growth of cancer cells by inhibiting cell cycle, energy metabolism,
and DNA repair pathways (10, 14). Kushen is considered to
be the principal herb and major contributor to the molecular
effects of CKI. Many published studies have reported on the
alkaloids and flavonoids contained in CKI, most of which are
extracted from Kushen. These compounds have been reported to
have a variety of bioactivities, including antitumor, antioxidant,
and anti-inflammatory activities (15, 16). However, there is no
literature that mentions the role of Baituling in CKI. Therefore,
current studies are not sufficient to provide a rational framework
for CKI prescription or explain its molecular mechanisms.
In this report, we break down the formula into its individual
components in order to study the herbal compatibility of CKI.
By comparing transcriptome changes in MDA-MB-231 cells
between CKI and single herbal extract treatments, we found that
Kushen extract alone, perturbed most of the pathways through
which CKI exerts its effects on cancer cells. However, integrating
Kushen with Baituling can enhance the effects of Kushen alone
on cancer-related pathways and in addition can activate innate
immune functions. These results support the TCM rationale
behind the CKI formula and confirm RNA-sequencing as a
useful tool for the identification of candidate mechanisms in
TCM research.
MATERIALS AND METHODS
Cell Culture and Drugs
MDA-MB-231 (ATCC Cat# CRM-HTB-26, RRID:CVCL_0062),
HepG2 (ATCC Cat# HB-8065, RRID:CVCL_0027) and
A431 (ATCC Cat# CRL-7907, RRID:CVCL_0037) cells
were purchased from ATCC (VA, USA). All cell lines were
cultured at 37◦C with 5% CO2 in DMEM (Thermo Fisher
Scientific, MA, USA) with 10% fetal bovine serum (Thermo
Fisher Scientific). CKI, Baituling, and Kushen injections
were provided by Zhendong pharmaceutical Co.Ltd (China).
Baituling and Kushen injections were manufactured using
the same processes as CKI and diluted to the equivalent
concentration of CKI (total alkaloid concentration at 2 mg/ml).
The concentration at 2 mg/ml (total alkaloid concentration for
CKI, and equivalent total alkaloid concentration for Kushen
and Baituling injections) was used in all cell assays and
transcriptome analysis.
All in vitro assays were conducted in 6-well or 96-well plates.
The seeding density was 4 × 105 for 6-well plates across all
three cell lines. For 96-well plates, MDA-MB-231 cells, A431 cells
and HepG2 cells were seeded at 1.6 × 105cells/well, 8 × 104
cells/well, and 4 × 103cells/well respectively. Cells were cultured
overnight before drug treatment and the treatment time was 48 h
for all assays.
Components Comparison With HPLC
CKI, Kushen or Baituling injection was diluted 1:20 with
MilliQ water and then analyzed on a photodiode-array
UV-Vis detector equipped Shimadzu HPLC (Japan) with a
preparative C18 column (5µm, 250 × 10mm, Phenomenex,
CA, USA). The recording range is from 200 to 280 nm,
with monitoring at 215 nm. 0.01M ammonium acetate
(adjusted to pH 8.0, solvent A) and acetonitrile + 0.09 %
trifluoroacetic acid (solvent B) were used as mobile phase
and flow rate is 2 ml/min with linear gradient elution (0min,
100 % A; 60min, 65 % A, 70min, 100 % A). Nine Standard
compounds, including Oxymatrine, Oxysophocarpine, N-
methylcytisine, Matrine, Sophocarpine, Trifolirhizin, Adenine,
Sophoridine (Beina Biotechnology Institute Co., Ltd, China),
and macrozamin (Zhendong Pharmaceutical Co.Ltd, China),
were used to characterize peaks in the HPLC profile.
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FIGURE 1 | HPLC profiles of CKI, Kushen and Baituling injections. Nine component compounds characterized using standard compounds are marked with red
arrows.
Cell Viability Assay
Cells were cultured and treated in 96-well plates. After
48 h drug treatment, 50 µl of XTT:PMS (at 1 mg/ml
and 1.25mM, respectively, and combined at 50:1 ratio,
Sigma-Aldrich, MO, USA) was added into each well
and incubated 4 h for the measurement of cell viability.
A Biotrack II microplate reader was used to detect the
absorbance at 492 nm.
Apoptosis Rate With Cell Cycle Assay
After treatment, cells were harvested from 6-well plates and
stained with propidium iodide (PI; Sigma-Aldrich) as previously
described (17). The stained cells were quantified on a BD LSR
Fortessa-X20 (BD Biosciences, NJ, USA) and the data were
analyzed with FlowJo software (TreeStar Inc., OR, USA).
qPCR for Transcriptome Validation
The assay was performed as previously described (10). The
sequences of all primers are shown in the Supplementary Table.
RNA Extraction and Sequencing
After treatment with injections, MDA-MB-231 cells were
harvested from 6-well plates and snap-frozen with liquid
nitrogen. Total RNA was isolated using the PureLink RNA
mini kit (Thermo Fisher Scientific). Quality and quantity
of RNAs were measured with a Bioanalyzer at the Cancer
Genome Facility of the Australian Cancer Research Foundation
(Australia) to ensure RIN>7.0 and sent to Novogene (China) for
sequencing with paired-end 150 bp reads on an Illumina HiSeq
X platform.
Transcriptome Data Analysis
The adaptors and low-quality sequences in raw reads were
trimmed with Trim_galore (v0.3.7, Babraham Bioinformatics)
using parameters: —stringency 5 —paired. STAR (v2.5.3a)
was used to align reads to reference genome (hg19,
UCSC) with parameters: —outSAMstrandField intronMotif
—outSAMattributes All —outFilterMismatchNmax 10 —
seedSearchStartLmax 30(18). Differentially expressed genes were
Frontiers in Oncology | www.frontiersin.org 3 July 2019 | Volume 9 | Article 632
Shen et al. Mechanistic Contribution of Herbal Extracts
FIGURE 2 | Comparison of the effect of CKI and single herb injections on cancer cell lines. (A,B) Viability and the percentage of apoptotic cells treated with different
injections for 48 h. (C) q-PCR validation of RNA sequencing results. The expression value in transcriptome was normalized as CPM (counts per million) using a TMM
(Trimmed-Mean of M values) methods from edgeR package. Results are represented as means ±SEM (n = 9). Statistical analyses were performed using the t-test
compared to untreated “Media” (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
calculated with edgeR (v3.22.3) and selected with false discovery
rate (FDR) < 0.05 and Log fold change >1 or <-1(19).
The GO and KEGG over-representation analyses were
performed with ClueGO and visualized with Cytoscape v3.6.0
with following parameters: right-sided hypergeometric test for
enrichment analysis; p-values were corrected for multiple testing
according to the Benjamini-Hochberg method and biological
process at 3rd level for GO terms (20, 21). The Signaling
Pathway Impact Analysis (SPIA) package in R was used to
conduct the pathway perturbation analysis using all DE genes
(FDR < 0.05) (22). R Pathview package was used to visualize
specific KEGG pathways (23). String (V11.0) was used to identify
protein-protein interactions with a threshold of 0.4 for minimum
interaction score (24).
ELISA for IL-1β Level
A431 cells were treated with different injections for 48 h in 96-
well plates and the cell culture supernatant was collected and
tested for the level of IL-1β by ELISA using human interleukin-
1 beta ELISA kit (Biosensis, CA, USA) according to the kit
protocol. The absorbance at 450 nm was detected with Multiskan
Ascent Plate Reader.
RESULTS
HPLC Comparison of the Composition of
CKI and Single Extract Injections
In order to obtain information about plant specific components
in CKI, we used high-performance liquid chromatography
(HPLC) to compare the compounds in CKI and two single
herb extracts/injections (Figure 1). From the chromatographic
profile, it can be seen that Kushen injection contributes
most of the major chemical components in CKI. In contrast,
few compounds were detected in Baituling injection, which
only contributes one major compound to CKI. Based on
comparison with 9 reference standard compounds, 8 main
compounds derived from Kushen (adenine, N-methylcytisine,
sophorodine, matrine, sophocarpine, oxysophocarpine,
oxymatrine, and trifolirhizin) are shown to contribute to
CKI. Macrozamin, which is used as a control marker for
Baituling during manufacturing, only appeared in CKI and
Baituling injection. These results indicate that CKI contains
major compounds from both Kushen and Baituling, and
Kushen contributes most of the major chemical components
in CKI.
Comparison of the Anticancer Effects
Between CKI and Single Injections
Our previous results showed CKI suppressed the proliferation
of and induced apoptosis in MCF-7 cells (10). To determine
whether single injections had similar phenotypic effects as
CKI, we conducted XTT assays to measure cell viability using
three different cell lines; MDA-MB-231, A431 and HepG2.
Results showed that Kushen had stronger cytotoxic effects
than Baituling in all three cell lines. However, neither of
the single injections had apoptotic effects comparable to
CKI (Figure 2A) based on rates of apoptosis determined
by flow cytometry with propidium iodide (PI) staining.
Consistent with XTT cell viability results, more apoptotic
cells were found in CKI than single injections treatments and
Baituling had the smallest effect on apoptosis of the three
injections (Figure 2B).
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FIGURE 3 | Significantly differentially expressed genes shared by Kushen (2 mg/ml) and CKI (2 mg/ml) treated cells and their functional enrichment analysis. (A) Venn
diagram showing the number of differentially regulated genes in MDA-MB-231 cells treated with Kushen (KS; blue) or CKI (yellow) compared to untreated cells. (B,C)
Over-represented KEGG pathways and GO terms (Biological Process at 3rd level, GO terms with FDR < 0.01 were showed and FDR < 0.05 were listed in
Supplementary Table 5) for genes similarly regulated by Kushen and CKI. Node size is proportional to the statistical significance of over-representation and colors
represent the proportion of up or down-regulated genes (yellow=up-regulated and blue=down-regulated). Similar GO terms are clustered (with representative terms
shown in bold) and connected with edges.
Comparison of MDA-MB-231
Transcriptomes From CKI and Single
Injection Treatments
In order to elucidate the molecular mechanisms of herbal
compatibility in CKI, we carried out transcriptome profiling
from CKI and the single injection treated MDA-MB-231
cells. Triplicate samples for each treatment clustered well in
multidimensional scaling plots and different treatments were
clearly separated (Supplementary Figure 1). Although CKI and
Kushen injection have similar chemical profiles, the inclusion
of Baituling in CKI is sufficient to change the transcriptome
of MDA-MB-231 cells compared to Kushen single injection
treatment.We used edgeR (19) to identify differentially expressed
(DE) genes for each injection treatment compared to untreated.
Only 253 DE genes were identified in Baituling treated
cells, which is much less than CKI and Kushen treatments
(Supplementary Figure 2). In addition, we also identified DE
genes for CKI treatment compared to Kushen treatment to
identify the effects of Baituling in CKI (Supplementary Table 3).
To validate the results of transcriptome analysis, we
performed quantitative PCR for several genes known to be
important read-outs for the effects of CKI; TP53, CYD1A1, and
CCND1. Their expression levels confirmed the interaction of
Baituling with Kushen observed in the overall RNA sequencing
results (Figure 2C).
Similar Effects of CKI and Kushen Single
Injection on MDA-MB-231 Cells
Because Kushen is considered to be the primary active herb in
CKI, and also we observed much more shared DE genes between
CKI and Kushen treatments than between CKI and Baituling
treatments (Supplementary Figure 2), we first examined the
overlap of DE genes between Kushen and CKI. We identified
2,520 and 3,236 DE genes in cells treated with Kushen or CKI
compared to untreated cells, respectively. By comparing these
two DE gene sets, we identified 2,039 genes shared between the
two groups (Figure 3A), indicating that Kushen contributed to
the majority of effects from CKI.
In order to better understand the functions of shared DE genes
between Kushen and CKI, we performed over-representation
analysis using Gene Ontology (GO) and Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathways for these 2,039 genes
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FIGURE 4 | Pathway perturbation analysis for CKI and single injections on MDA-MB-231 cells. (A,B) Perturbation accumulation and significance of perturbation for
different KEGG pathways treated with different injections. Positive perturbation accumulation values mean the pathway is activated and vice versa. Dot colors indicate
whether the pathway was significantly perturbed by CKI and/or Kushen. (C) Heatmap showing the perturbation value of shared significantly perturbed pathways for
the three injections. Table on the right-bottom corner shows the correlation coefficients for the perturbation value for the three injections. “*” and “***” represent p <
0.05 and p < 0.001 respectively (Pearson’s correlation test).
(Figures 3B,C; Supplementary Table 5). The results showed that
cell cycle- and DNA replication-related pathways and terms were
largely down-regulated by both Kushen and CKI. Based on our
previous publications, perturbed regulation of genes in these
pathways and annotated by these terms was associated with
the observed cell viability and apoptotic effects CKI on cancer
cells (10, 14). Other terms showing perturbation of metabolic
processes and cell migration identified in this study, such as
“pyrimidine metabolism,” “steroid biosynthesis,” and “positive
regulation of locomotion,” also showed up in our previous
research on the effects of CKI (25). Altogether, these results
indicated that Kushen was very important to the major molecular
consequences of CKI treatment, and perturbed most of the
biological functions perturbed by CKI, resulting in reduced
viability and and increased apoptosis in cancer cells.
Different Effects of CKI and Single
Injections on MDA-MB-231 Cells
Although the above results for enrichment analysis showed
that Kushen and CKI mainly regulate the same pathways,
they did not specifically show the magnitude and direction of
these perturbations. We, therefore, performed Signaling Pathway
Impact Analysis (SPIA) to compare the significantly perturbed
functional pathways across the different treatments. Ninety-two
pathways were found to be significantly perturbed by CKI while
only 30 of them were shown to be activated. For Kushen and
Baituling, the ratios of activated/inhibited were 29/100 and
24/58, respectively (Supplementary Table 4). Clearly, Baituling
perturbed fewer pathways, but the ratio of activated/inhibited
was higher than for Kushen or CKI. Interestingly, most pathways
were perturbed in the same way (inhibited or activated) by CKI
and Kushen as shown in Figures 4A,B with very few pathways
showing different directions of perturbation.
This similarity of effects between Kushen and CKI could also
be seen in the high level of correlation for pathway perturbation
between Kushen and CKI (0.83 correlation coefficient) compared
to (0.33 correlation coefficient) for Baituling and CKI. CKI also
had stronger perturbation effects on most pathways (Figure 4C).
In pathways contributing to cytotoxic effects in cancer cells,
such as cell cycle, p53 signaling pathway, proteoglycans in
cancer and pathways in cancer, Baituling perturbed the pathways
in the same direction as Kushen and seemed to reinforce
Frontiers in Oncology | www.frontiersin.org 6 July 2019 | Volume 9 | Article 632
Shen et al. Mechanistic Contribution of Herbal Extracts
FIGURE 5 | Comparison of gene expression changes caused by Baituling and Kushen treatments in the cytokine-cytokine receptor interaction pathway. Left half of
each box represents the gene expression change with Baituling treatment and the right half represents the effect of Kushen treatment. White or gray colors indicate no
significant change in gene expression as a function of treatment.
those effects in CKI. However, the cytokine-cytokine receptor
interaction pathway was very interesting as it was perturbed
in an opposite fashion in Baituling compared to Kushen
and did not show up as significantly perturbed by CKI
treatment (Supplementary Figure 3). By comparing DE genes
for Baituling and Kushen in the cytokine-cytokine receptor
interaction pathway (Figure 5), we observed that many genes
were oppositely regulated by the two single injections, such
as genes in the CXC subfamily and IL6/12-like cytokine and
receptor genes, which supported the SPIA results.
The Functions of Baituling in CKI
In order to investigate the function of Baituling in CKI, we
identified the DE genes of CKI treatment compare to Kushen
treatment. Only 308 DE genes were found (Figure 6A). KEGG
analysis of these genes showed that with the exception of steroid
hormone biosynthesis and transcriptional misregulation in
cancer, all other pathways were related to immune function,
and most genes in this set were up-regulated (Figure 6B,
Supplementary Table 5). This result was consistent with
findings in the SPIA analysis that Baituling tended to activate
immune-related pathways. The over-represented GO terms
for this gene set also included interferon-gamma production,
organ or tissue specific immune response and interleukin-2
production, all aspects of immune function and which only
contained up-regulated DE genes (Figure 6C).
The genes in the common set between Kushen and CKI
compared to Kushen (Figure 6A) were originally changed with
Kushen treatment and then further significantly regulated
in combination with Baituling (107 genes). Only three
pathways (IL-17 signaling, salmonella infection, and steroid
hormone biosynthesis) were over-expressed by genes in this
set, indicating Baituling could also modify functions related
to immune system and hormone function upregulated by
Kushen in CKI (Supplementary Figure 4). Furthermore,
24 genes appeared in both Baituling and CKI compared
to Kushen set (Figure 6A), which can be regarded as the
direct contribution from Baituling to the effects of CKI.
Analysis of known protein-protein interactions in this gene
set identified the IL-1 family and interacting proteins known
to modulate immune function (Figure 7A). To verify that
IL-1 protein levels were also changing as predicted, we carried
out an ELISA assay to measure the IL-1β beta levels in
different treatments. We were able to demonstrate that the
increased IL-1β level in CKI treatment compared to untreated
was mainly related to the effects of Baituling (Figure 7B).
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FIGURE 6 | DE genes regulated by Baituling in MDA-MB-231 cells line and their functional enrichment analysis. (A) Venn diagram showing the number of differentially
regulated genes with CKI compared to Kushen (CKI-KS—Blue) and single herb injections (KS—Green or BTL—Yellow) compared to untreated. (B,C)
Over-represented KEGG pathways and GO terms (Biological Process at 3rd level) for DE genes calculated by CKI compared to Kushen treated. Node size is
proportional to the statistical significance of over-representation and colors represent the proportion of up or down-regulated genes (yellow=up-regulated and
blue=down-regulated). Terms are clustered based on similar GO group (shown in bold) and related ones are connected with edges.
Altogether, these results showed that Baituling contributed to
the effects of CKI primarily by altering functions related to the
immune system.
In summary, we characterized the herbal compatibility of
Kushen and Baitulin in CKI by comparing the individual
effects of the herbal extracts to the combined extract using
transcriptome analysis. In this fashion, we were able to explain
the origin of CKI’s different effects in MDA-MB-231 cells.
In addition, we also showed that Baituling could enhance
the reduction of cell viability and increased apoptosis effects
from Kushen in CKI. These results not only explained the
specific molecular basis of the TCM rationale of combining
Kushen with Baituling but also illustrate a general method
to apply transcriptome analysis to study herbal compatibility
in TCM.
DISCUSSION
It is undeniable that chemical composition is the basis of
therapeutic effects from herbal TCM. However, because the
identification and quantification of all compounds for even
a single herb are still extremely difficult if not impossible,
there is a pressing need for alternative methods to conduct
TCM research, particularly with respect to the study of herbal
compatibility (26, 27). Herbal compatibility has a basis in
TCM theory, but TCM theory is not generally accepted in
Western medicine and it is difficult to map concepts from TCM
theory to Western medicine. Methods that can identify the
molecular consequences of TCM formulations and individual
herbs can begin to provide such a map. One view of TCM
is that it perturbs multiple targets or pathways with multiple
low activity components to generate relatively strong effects.
This is in contrast to the standard approach for pharmaceutical
drug development which seeks to identify single compounds
that inhibit a single pathway or target. However, this method
of using one or several active compounds as representative of
single herbs is problematic (11) for understanding the roles of
individual plant extracts in TCM formulations. This is illustrated
by our results; although containing similar amounts of the
main chemical compounds, CKI has much stronger effects
than Kushen extract alone. Therefore, a formula disassembly
approach that uses single herbs is a practical way to study
herbal compatibility. Combined with omics techniques and
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FIGURE 7 | Validation of IL-1β expression changes regulated by Baituling. (A) Diagram showing protein-protein interactions for common DE genes between CKI
compared to Kushen, and Baituling compared to untreated. (B) Comparison of expression levels and protein concentration for IL-1β with different treatments. Top
panel; IL-1β gene expression levels determined by RNA sequencing, bottom panel; levels of IL-1β in culture supernatant measured by ELISA. Statistical analyses
were performed using the t-test compared to untreated “Media” (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
network analysis, we can represent the mechanisms of TCM
herbal compatibility as interactions between target networks
familiar to Western medicine. In this report, we took CKI, a
prescription containing only two herbs, as a proof of principle.
However, related methods can easily be applied to more
complex formulae.
As a frequently used herb, and because it is considered to
contain the main bioactive components in CKI, Kushen or its
main alkaloids and flavonoids are commonly used to represent
CKI in studies (28, 29). Furthermore, TCM theory also regards
Kushen as the primary herb in CKI. Our results support these
hypotheses and TCM theory at different levels. First, at the
chemical level, HPLC profiles showed that the source of most
major components in CKI is Kushen. Second, in terms of
overall efficacy, Kushen has much stronger cytotoxic effects
than Baituling on various cell lines. Third, at the gene level,
a high proportion of DE genes regulated by Kushen or CKI
are the same, and most of them are consistently up- or down-
regulated. Furthermore, important genes are also regulated both
by Kushen and CKI. Cytochrome P450 family 1 subfamily
A member 1 (CYP1A1) gene, a steroid metabolizing enzyme
which is important for steroid hormone responsive cancers
and shown as the most over-expressed gene with CKI in our
previous results, is also highly overexpressed by Kushen but not
Baituling (30, 31). Also, the down-regulation of the TP53 gene
primarily results from Kushen. Our previous results based on
CKI treated cells underwent apoptosis while expression of TP53
decreased, which indicates the apoptosis induced by Kushen and
CKI is not TP53-dependent (10). Finally, GO and KEGG over-
representation analysis also indicated that the genes in major
cancer related pathways and terms perturbed by CKI, including
cell cycle, DNA replication, and cell migration, are induced
by the shared DE gene set between Kushen and CKI. Taken
together, our findings agree with TCM theory which considers
Kushen as the principle herb in CKI, and they map this specific
part of TCM theory to effects on specific genetic networks
and pathways.
On the other hand, we could find no Baituling literature
and studies on macrozamin to support its application in CKI
(32). From our HPLC and cytotoxic assay results, Baituling
extract does not containmany components and has no significant
effects on cancer cells. In addition, RNAseq analysis of Baituling-
treated samples are close to the untreated samples in the
multidimensional scaling plot, and only 253 DE genes compared
to untreated were detected. However, after comparing the
differences between CKI and Kushen, we found Baituling has a
strong reinforcing effect on Kushen. The SPIA results showed
Baituling can enhance many pathways’ perturbation strength
compared to Kushen treatment, including cell cycle, pathways in
cancer and proteoglycans in cancer. In addition, many DE genes
in immune-related pathways and GO terms are over-represented
in CKI compared to Kushen. Together with the opposing
direction of perturbation for the cytokine-cytokine receptor
interaction pathway caused by Kushen and Baituling, we can
conclude Baitulingmay also contribute to the immune regulatory
effects of CKI. This was confirmed by our measurements of IL-
1β, which was significantly up-regulated by Baituling and CKI.
In summary, our results indicate that Baituling, an adjuvant herb
in CKI according to TCM theory, may enhance the anticancer
effects of Kushen and contribute to immune regulation.
In conclusion, we have explained the TCM herbal
compatibility of CKI in the context of pathway perturbations
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using transcriptome analysis. Kushen primarily contributes to
CKI effects on cancer cells by perturbing cell cycle regulation
and other functions (10, 14), whereas Baituling enhanced
potential anticancer effects for Kushen and activated the
immune system. Therefore, the two herbs in CKI have
complementary effects, in accordance with formulation
theory in TCM. Compared to previous studies on herbal
compatibility, our method can explain the beneficial interaction
pattern of herbs in TCM formulae in a more systematic and
comprehensive fashion.
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